Role of Vitamin D and Vitamin D Polymorphisms in COVID-19 Risk and Severity in Children: A Systematic Review

TL;DR

This study reviews how vitamin D levels and genetic variations may affect children's risk and severity of COVID-19.

Contribution

The paper systematically reviews the role of vitamin D and VDR polymorphisms in pediatric COVID-19 and MIS-C, highlighting potential risk factors and biomarkers.

Findings

43.05% of pediatric COVID-19 patients had low vitamin D levels.

Mean serum 25(OH)D levels in children with COVID-19 were significantly low (17 ng/mL).

Vitamin D deficiency and VDR FokI polymorphism may be risk factors for pediatric COVID-19.

Abstract

The role of vitamin D in the susceptibility to coronavirus disease 2019 (COVID‐19) disease has been investigated since the beginning of the pandemic, but there is still scarce data on children. We investigated the impact of vitamin D status and the related genetic variants on COVID-19 vulnerability and severity of the disease in children. A systematic review was performed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, to identify reports on vitamin D status and genetic polymorphisms, their association with the susceptibility of children to COVID-19 and multisystem inflammatory syndrome in children (MIS-C), and the effect of supplementation on the clinical course. Of an initial total of 279 articles, 26 studies, published between September 2020 and May 2023, were finally included in this review according to inclusion criteria. Quantitative data provided by 11 studies revealed that 43.05% of pediatric COVID-19 patients had low vitamin D levels. Mean serum 25(OH)D levels were observed to be significantly low in COVID-19 cases, with an estimated pooled mean value of 17 ng/mL, as provided by 16 studies. Vitamin D deficiency and the vitamin D receptor (VDR) FokI polymorphism may suggest independent risk factors for susceptibility to COVID-19 in the pediatric population. The 25(OH)D level may constitute a significant biomarker associated with the COVID-19 severity and MIS-C. While supplementation of COVID-19 cases with vitamin D showed favorable results, the effect on the outcome of the disease remains uncertain.

Figures